Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA
Naomi V Dahl,1 Robert F Kaper,2 William E Strauss,1 Frank A Corvino,3 Marko Zivkovic3 1Medical Affairs, 2Medical & Scientific Affairs, AMAG Pharmaceuticals, Inc., Waltham, MA, 3Genesis Research, Hoboken, NJ, USA Objective: Ferumoxytol has demonstrated superior efficacy compared with oral iro...
Main Authors: | Dahl NV, Kaper RF, Strauss WE, Corvino FA, Zivkovic M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-09-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/cost-effectiveness-analysis-of-intravenous-ferumoxytol-for-the-treatme-peer-reviewed-article-CEOR |
Similar Items
-
Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer
by: Vadhan-Raj S, et al.
Published: (2017-12-01) -
A budget impact analysis of parenteral iron treatments for iron deficiency anemia in the UK: reduced resource utilization with iron isomaltoside 1000
by: Pollock RF, et al.
Published: (2017-08-01) -
Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders
by: Ford DC, et al.
Published: (2016-07-01) -
Health-related quality of life in patients with iron deficiency anemia: impact of treatment with intravenous iron
by: Strauss WE, et al.
Published: (2018-08-01) -
Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis
by: Eleonora Riccio, et al.
Published: (2020-02-01)